BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22041521)

  • 1. A p53 gene mutation in malignant fibrous histiocytoma associated with bone infarction.
    Yamamoto Y; Takakuwa Y; Kuroda M; Nakashima H; Washimi Y; Ishimura D; Yamada H
    Tohoku J Exp Med; 2011 Nov; 225(3):215-20. PubMed ID: 22041521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
    Taubert H; Würl P; Meye A; Berger D; Thamm B; Neumann K; Hinze R; Schmidt H; Rath FW
    Cancer; 1995 Oct; 76(7):1187-96. PubMed ID: 8630896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of germline and tumor mutations of p53 gene in familial occurrence of soft tissue sarcomas.
    Kudawara I; Matsumine A; Ohzono K
    J Surg Oncol; 2007 Mar; 95(4):347-50. PubMed ID: 17192950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutation and MDM2 overexpression in a case of primary malignant fibrous histiocytoma of the jejunum.
    Jiao YF; Nakamura S; Sugai T; Habano W; Uesugi N; Oikawa M; Sato T
    APMIS; 2002 Feb; 110(2):165-71. PubMed ID: 12064872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of point mutation of p53 gene by silver staining PCR-SSCP in paraffin-embedded malignant fibrous histiocytoma].
    Li J; Yang G; Li G
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):13-5. PubMed ID: 8732103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma.
    Grote HJ; Schneider-Stock R; Neumann W; Roessner A
    Virchows Arch; 2000 May; 436(5):494-7. PubMed ID: 10881744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic malignant fibrous histiocytoma, inflammatory myofibroblastic tumor, and inflammatory pseudotumor related to autoimmune pancreatitis: characterization and differential diagnosis.
    Mizukami H; Yajima N; Wada R; Matsumoto K; Kojima M; Klöppel G; Yagihashi S
    Virchows Arch; 2006 May; 448(5):552-60. PubMed ID: 16538442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant fibrous histiocytoma associated with diaphyseal medullary stenosis.
    Douya H; Yokoyama R; Beppu Y; Hasegawa T
    Clin Orthop Relat Res; 2002 Jul; (400):211-6. PubMed ID: 12072764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiosarcomas associated with bone infarcts.
    Abdelwahab IF; Klein MJ; Hermann G; Springfield D
    Skeletal Radiol; 1998 Oct; 27(10):546-51. PubMed ID: 9840390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
    Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the p53 gene in postradiation sarcoma.
    Nakanishi H; Tomita Y; Myoui A; Yoshikawa H; Sakai K; Kato Y; Ochi T; Aozasa K
    Lab Invest; 1998 Jun; 78(6):727-33. PubMed ID: 9645763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant p53 G-->A transition mutation and enhanced cell proliferation in uterine sarcomas of CBA mice treated with 1,2-dimethylhydrazine.
    Trukhanova LS; Hong HH; Sills RC; Bowser AD; Gaul B; Boorman GA; Turusov VS; Devereux TR; Dixon D
    Toxicol Pathol; 1998; 26(3):367-74. PubMed ID: 9608642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W; Kong X; Cao HL; Wang X; Gao JF; Wu RL; Wang XC
    Ai Zheng; 2008 Jan; 27(1):8-11. PubMed ID: 18184456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
    Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
    Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant fibrous histiocytoma of bone treated by resection and prosthesis: a case report.
    Bravo PA; Mena VD; Chicharro E
    Int Orthop; 1983; 7(2):105-11. PubMed ID: 6100448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of p53 gene in childhood malignant solid tumors.
    Kusafuka T; Fukuzawa M; Oue T; Komoto Y; Yoneda A; Okada A
    J Pediatr Surg; 1997 Aug; 32(8):1175-80. PubMed ID: 9269965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CASE REPORTS: malignant fibrous histiocytoma of bone arising in chronic osteomyelitis.
    Zlowodzki M; Allen B; Schreibman KL; Vance RB; Kregor PJ
    Clin Orthop Relat Res; 2005 Oct; 439():269-73. PubMed ID: 16205169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relatively high frequency of p53 gene mutations in multiple and malignant phaeochromocytomas.
    Yoshimoto T; Naruse M; Zeng Z; Nishikawa T; Kasajima T; Toma H; Yamamori S; Matsumoto H; Tanabe A; Naruse K; Demura H
    J Endocrinol; 1998 Nov; 159(2):247-55. PubMed ID: 9795365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.